Saga Pure ASA Boosts Stake in Vistin Pharma

Vistin Pharma ASA (DE:VP4) has released an update.

Saga Pure ASA has increased its stake in Vistin Pharma ASA by acquiring an additional 250,000 shares at a price of NOK 25.13 each, taking its total ownership to 1.47%. Following the transaction, board member Øystein Stray Spetalen and his associated companies hold a combined 5.02% of Vistin Pharma. The purchase took place on the Oslo Stock Exchange on September 13, 2024.

For further insights into DE:VP4 stock, check out TipRanks’ Stock Analysis page.